NCT06513247 - Screening Program for Type 1 Diabetes in a High-Risk Population | Biotech Hunter

Enrollment

1,300

Participants

Timeline

Start Date

May 26, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2029

Conditions

Type 1 Diabetes

Interventions

DIAGNOSTIC_TEST

screening for Islet autoantibody

IAA, GADA, IA-2A, Zn-transporter 8 autoantibodies

DIAGNOSTIC_TEST

HLA phenotype and genetic risk score

using DBS filter paper

Trial Locations (1)

RECRUITING

The University Diabetes Centre at King Saud University Medial CIty, Riyadh